Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Good Girl Rx vs Tablet Health

Good Girl Rx
Graded #251

Higher grade

vs+16.299999999999997
Tablet Health
Graded #495

Lower grade

The verdict

Good Girl Rx takes it — 63.9/100 to 47.6/100.

Good Girl Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Good Girl Rx (Good Girl LLC) offers compounded semaglutide and tirzepatide in injectable, microdose, and oral dissolving tablet (ODT) formats.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTablet Health +2
43
45
Dose & formulationGood Girl Rx +37
88
51
Clinical oversightGood Girl Rx +44
81
37
Labs & monitoringGood Girl Rx +2
52
50
FulfillmentGood Girl Rx +12
69
57
Contract termsTablet Health +14
41
55
Good Girl Rx · left barTablet Health · right bar

The numbers

MetricGood Girl RxTablet Health
WeighScore63.9/10047.6/100
GradeCC
Scorecard rank#251#495
Semaglutide$134/mo (starting dose, annual plan, compounded)Not disclosed
Tirzepatide$235/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesYes
Good Girl Rx

Graded #251 · C

Strengths

  • LegitScript certified
  • Multiple formats — injectable, microdose, and ODT pills — for both semaglutide and tirzepatide
  • Dispensed by licensed 503A or 503B pharmacies
  • Limited brand-name options available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • Named legal entity with a Nashville address

Where it loses points

  • State availability not disclosed
  • Very new brand — founded January 2025
  • Celebrity-founded (Savannah Chrisley) — brand vs clinical credibility
Tablet Health

Graded #495 · C

Strengths

  • LegitScript Certified
  • Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
  • Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
  • Mid-tier pricing starting $179–$299/mo across all four product variants
  • No commitment — cancel anytime

Where it loses points

  • States served not published — you must complete the intake quiz to learn eligibility
  • No founder, CEO, medical director, or pharmacist-in-charge named anywhere
  • No BBB profile found
  • Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard